ADRB3 and cancer: Recently, since EWS cells are susceptible to an increased oxidative stress, beta-3-adrenergic receptor (β3-AR) has been proposed as a putative target for a possible strategy in cancer therapy due to its ability to induce apoptosis in EWS cell lines by increasing the level of reactive oxygen species (ROS) [20].